27 - 29 May, 2026
Congress CenterBasel SwitzerlandDr. Gregory Segala, PhDChief Scientific Officer at FluoSphera SASpeaker
Profile
Gregory Segala, PhD, co-founder and Chief Scientific Officer of FluoSphera, co-invented FluoSphera’s tissue multiplexing technology, which combines multiple 3D microtissues in a single well. This versatile platform opens new possibilities by enabling the assessment of systemic drug effects, such as liver-mediated prodrug activation, and physiological crosstalk between diseased and healthy tissues.
Agenda Sessions
Early Identification of Interstitial Lung Disease Risk While Measuring ADC Efficacy in a Human Systemic In Vitro Platform
, 11:30View Session